GROW Small Cap Equity Fund Covered Its Position in Harrow (HROW) in Q1

2 hours ago 6

Soumya Eswaran

Tue, June 23, 2026 astatine 7:06 AM CDT 2 min read

Grow Funds, an concern Advisor, released its Q1 2026 capitalist missive for "GROW Small Cap Equity Long/Short Fund". A transcript of the missive tin beryllium downloaded here. In Q1 2026, GROW Small Cap Equity Long/Short L.P (Fund) returned 4.18%, outperforming the Russell 2000 Growth Index's –2.80%, HFRI Equity Hedge Index's -0.24%, and the HFRI Fundamental Growth Index's 0.47% returns. Long positions and hedges, and abbreviated positions, safeguarded the portfolio amid the volatility driven by the Iran War. In addition, delight cheque the Strategy's apical 5 holdings to cognize its champion picks successful 2026.

In its first-quarter 2026 capitalist letter, Grow Funds highlighted stocks similar Harrow, Inc. (NASDAQ:HROW). Harrow, Inc. (NASDAQ:HROW) is simply a US-based pharmaceutical institution that focuses connected the find and improvement of ophthalmic pharmaceutical products. On June 22, 2026, Harrow, Inc. (NASDAQ:HROW) closed astatine $42.41 per share. One-month instrumentality of Harrow, Inc. (NASDAQ:HROW) was 24.11%, and its shares gained 33.74% implicit the past 52 weeks. Harrow, Inc. (NASDAQ:HROW) has a marketplace capitalization of $1.58 billion.

Grow Funds stated the pursuing regarding Harrow, Inc. (NASDAQ:HROW) successful its Q1 2026 capitalist letter:

"Harrow, Inc. (NASDAQ:HROW) develops ophthalmic therapies, helping patients negociate chronic and acute oculus conditions. While we similar the institution and its maturation prospects, we thought that determination was a disconnect successful precocious thoroughfare net expectations versus the underlying maturation of the company. HROW disappointed connected net and we covered the position."

Jim Cramer connected Harrow, Inc. (HROW) – "Eye Care's a Good Biz – If It Makes Money, Don't Walk Away Pre-Breakout"

Harrow, Inc. (NASDAQ:HROW) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 22 hedge money portfolios held Harrow, Inc. (NASDAQ:HROW) astatine the extremity of the archetypal quarter, compared to 24 successful the erstwhile quarter. While we admit the imaginable of Harrow, Inc. (NASDAQ:HROW) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

In another article, we covered Harrow, Inc. (NASDAQ:HROW) and shared a bullish thesis on the company. In addition, delight cheque retired our hedge money capitalist letters Q1 2026 page for much capitalist letters from hedge funds and different starring investors.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.

Read Entire Article